Oxford Textbook of Oncology

Dr Andrew Davies, Consultant in Palliative Medicine, Royal Surrey County Hospital; Review for Supportive Care in Cancer I would recommend anyone considering buying an oncology textbook, and particularly those who work in oncology support services, to consider this textbook as it is well set out, easy to read, easy to comprehend, and covers all of the important aspects of modern day oncology.

Alexander A. Shtil, Recent Patents on Anticancer Drug Discovery An outstanding gift to the international scientific community... The new textbook is an excellent demonstration of this multifaceted and astonishingly variable problem, as well as of the latest achievements in its understanding and practical management.

Anticancer Research Vol. 36 (2016) This volume provides a comprehensive account of the multiple aspects of best practice in the discipline, making it an indispensable resource for oncologists of all grades and subspecialty interests.

Professor Jaak Ph. Janssens, European Journal of Cancer Prevention The Oxford Textbook of Oncology is what it is meant to be: a textbook with comprehensive information of the actual status of oncology... an indispensable and attractive source of information.

Reviews from the previous edition

Oncology, Volume 63, 2002 The Oxford Textbook of Oncology is a classic and fresh approach to the field. It is a must for all libraries and all those who like to have a single up-to-date reference book that contains sufficient detail for the clinician in all subspecialties: surgery and chapters are sufficiently details to provide a reference for trainees in the field.


NEJM, Volume 347, Number 2, 2002 The Oxford Textbook of Oncology covers virtually the entire spectrum of malignant diseases in adults and children. It meets very high editorial and production standards: the organization, illustrations, and eye-pleasing typography are outstanding... I have high praise for this textbook.


JAMA, Volume 287, Issue 24, 2002 Under new editorship, the second edition is far more than an updated version of the first...the prose in the Oxford Textbook is exemplary...this textbook is unique among its peers in giving the sense that the authors are addressing the reader personally...an exception level of qualityRespect for the evidence-based medicine is apparent throughout the text...illustrative and anatomical drawing...of remarkable high quality...excellent discussion of doctor-patient communication in relation OT genetic counselling, psychological issues, and terminal cancers.


Biomedicine and Pharmacotherapy, 2002 A landmark referenceIt sets new standards for publishing in oncology offering a ground-breaking innovative approach to the filed combined with the quality, accuracy , and intellectual rigour you have come to expect from the world's most prestigious reference publisher.


Doody's Journal , 2002 This comprehensive textbook of oncology is the first new major textbook o...

David J. Kerr, Professor of Cancer Medicine, Nuffield Division of Clinical Laboratory Sciences, Nuffield Department of Medicine, University of Oxford, Oxford, UK, Honorary Professor of Oncology, Xiamen and 2nd Military Universities, China, Honorary Professor, Seoul National University, Korea, Daniel G. Haller, Professor Emeritus, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA, Cornelis J. H. van de Velde, Professor of Surgery and Head, Department of Surgical Oncology, Leiden University Medical Center, The Netherlands, Michael Baumann, Cancer Research Center (DKFZ), Heidelberg, Germany and Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitat Dresden, Germany

Section 1: Hallmarks of Cancer 1: Douglas Hanahan and Robert A. Weinberg: The hallmarks of cancer 2: Shujuan Liu and Ahmed Ashour Ahmed: Growth factors and uncontrolled proliferation 3: Stefan Knapp: Cell signalling pathways 4: Simon Carr and Nicholas La Thangue: Cell cycle control 5: Amanda S. Coutts, Sandra Maniam, and Nicholas La Thangue: Cancer cell death 6: Yull E. Arriaga and Arthur E. Frankel: Angiogenesis 7: Andrew P. Mazar, Andrey Ugolkov, Jack Henkin, Richard Ahn, and Thomas V. O'Halloran: Invasion and metastases 8: Sir Walter Bodmer and Jenny Wilding: Genetic instability 9: E. Dikomey, K. Borgmann, M. Kriegs, W. Mansour, C. Petersen, and T. Rieckmann: DNA repair after oncological therapy 10: Andreas Trumpp: Biology of cancer stem cells 11: Richard D Kennedy, Manuel Salto-Tellez, D. Paul Harkin, and Patrick G Johnston: Biomarker identification and clinical validation 12: Campbell SD Roxburgh and Donald C McMillan: Cancer, immunity, and inflammation 13: Cameron Snell, Kevin C Gatter, Adrian L Harris, Francesco Pezzella: Cancer and metabolism Section 2: Etiology and Epidemiology of Cancer 14: Jonathan Samet: Smoking and cancer 15: Chris Boshoff: Viruses 16: Paula A. Oliveira: Chemical carcinogens 17: Klaus Trott: Radiation 18: Ellen Kampman and Franzel van Duijnhoven: Body fatness, physical activity, diet, and other lifestyle factors Section 3: Principles of Oncology 19: PG Boelens, CBM van den Broek, and CJH van de Velde: Practice points for surgical oncology 20: Annekatrin Singer, Stephanie E. Combs, Jurgen Debus, and Michael Baumann: Practice points for radiation oncology 21: David Kerr, Daniel Haller, and Jaap Verweij: Principles of chemotherapy 22: David N Church, Rachel S Midgley, and David J Kerr: Delivery of multidisciplinary cancer care 23: Michael Ong and Udai Banerji: Principles of clinical pharmacology: Introduction to pharmacokinetics and pharmacodynamics 24: Dan Sargeant and Qian Shi: Design and analysis of clinical trials 25: Eric A. Singer: Medical ethics in oncology 26: Jeffrey Peppercorn: Health economic assessment of cancer therapy Section 4: Population Health 27: Masoud Samiei: Cancer control: The role of national plans 28: Sarah Goltz and Julian Lob-Levyt: Cancer prevention: Vaccination 29: Hans-Joerg Senn, Nadir Arber, and Dirk Schrijvers: Cancer prevention: Chemoprevention 30: Andrew Evans, Simon Herrington, and Robert Steele: Population cancer screening 31: Henry T. Lynch, Carrie L. Snyder, and Jane F. Lynch (deceased): Familial cancer syndromes and genetic counselling Section 5: Support for the cancer patient 32: David Hui and Eduardo Bruera: Supportive palliative care 33: Neil Aaronson and Peter Fayers: Quality of life 34: Rachel L. Yung and Ann H. Partridge: Cancer survivorship and rehabilitation Section 6: Disease 35: Christine Chung, Andreas Dietz, Vincent Gregoire, Marco Guzzo, Marc Hamoir, Rene Leemans, Jean-Louis Lefebvre, Lisa Licitra, Adel El-Naggar, Brian O?Sullivan, Bing Tan, Vincent Vandecaveye, Vincent Vander Poorten, Jan Vermorken, and Michelle Williams: Cancer of the head and neck 36: Eric Van Cutsem, Christophe M. Deroose, Piet Dirix, Karin Haustermans, Tony Lerut, Philippe Nafteux, Hans Prenen, and Xavier Sagaert: Oesophageal cancer 37: Hideaki Bando, Takahiro Kinoshita, Yasutoshi Kuboki, Atsushi Ohtsu, and Kohei Shitara: Gastric cancer 38: Regina Beets-Tan, Bengt Glimelius, and Lars Pahlman: Rectal cancer 39: John Zalcberg, Stephen Fox, Alexander Heriot, Jon Knowles, Sam Ngan, Michael Michael, Kathryn Field, and Iris Nagtegaal: Colon cancer 40: J. Weitz, M.W. Buchler, Paul D Sykes, John P Neoptolemos, Eithne Costello, Christopher M Halloran, Frank Bergmann, Peter Schirmacher, Ulrich Bork, Stefan Fritz, Jens Werner, Thomas Brunner, Elizabeth Smyth, David Cunningham, Brian R. Untch, and Peter J. Allen: Pancreatic cancer 41: Graeme J Poston, Nicholas Stern, Jonathan Evans, Priya Healey, Daniel Palmer, and Mohandas K. Mallath: Hepatobiliary cancer 42: H. Richard Alexander, Jr., D